🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Opening Closed Doors – Microbubble-enhanced transcranial focused ultrasound ... 👉 Missed it or want to revisit the discussion? Watch the full recording now on YouTube: youtu.be/Sk_m4U8j9U0?... #NeuroOncology #EANO

EANO Youngsters Journal Club on July 14, 2026: Opening Closed Doors

YouTube video by EANO

youtu.be

Have you registered for #EANO2026 yet? Join the global #NeuroOncology community in Rome, Italy, from September 24–27, 2026. The #EANO Board is looking forward to welcoming you for four days of outstanding science, collaboration, and networking. 🎟 Register at the regular rate until August 12.

🎗️Today is Glioblastoma Awareness Day 2026 - a day to raise awareness of #glioblastoma. At EANO, we are constantly committed to advancing research, improving diagnosis, fostering international collaboration, and supporting the development of more effective treatments to improve outcomes for patients.

⏰ Regular Fees now available for #EANO2026 Missed the Early Bird? You can still secure your place at Europe’s leading #NeuroOncology congress. Join us in #Rome (IT), Sept 24–27, 2026, and connect with experts from around the world. 👉 eano.eu/eano2026/reg... 📅 Regular Fee period: July 8 – August 12

📢 The #EANO–EORTC CNS Metastasis Meeting 2027 marks a new chapter in #CNS metastasis research, bringing together researchers and clinicians to advance science and improve patient care. Abstract submission opens 31 Aug 2026. #CNSmetastasis2027 @eortc.org 👉 Learn more: www.eano.eu/eanomeetings...

🚨Just two days left! Early bird registration for #EANO2026 ends on July 7! Don't wait until fees go up to register. Learn more 👉https://eano.eu/eano2026/registration/ We are looking forward to meeting you in #Rome! #btsm #NeuroOncology #glioma #braintumor #neurosurgery

🧠 There's still time to register for the next #EANOYoungsters Journal Club! 📍 Opening Closed Doors 📅 14 July 2026 | 🕓 16:30 CEST 👉 Registration is free: zoom.us/webinar/regi... #Glioma #BrainTumor #EANOjournalclub

Promising advances in #glioma #immunotherapy – recently published in Nature Cancer: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial; 👉 Read more: www.nature.com/articles/s43... #EANOessentials

How to determine the extent of resection in meningiomas? Read our new manuscript on a comparison of Simpson grade vs. MRI across histomolecular subgroups! @eanoassociation.bsky.social @neuroonc.bsky.social doi.org/10.1227/neu....

Comparative Analysis of the Prognostic Value of Simpson... : Neurosurgery

tives. The aim of this study was to compare the prognostic performance of SG vs MRI-based EOR paradigms for predicting recurrence and survival across histomolecular subgroups. METHODS: International multicenter, retrospective cohort study included 475 meningiomas, resected between 1983 and 2024, which were classified by World Health Organization grade and molecular subgroups (DNA methylation, gene expression, and integrated grade). Area under the curve (AUC) was calculated for LFFR and overall survival (OS) from Cox models with a histomolecular subgroup and an EOR paradigm. Delta AUC (ΔAUC) compared EOR predictive performance within each subgroup, and log-rank comparisons of LFFR and OS were performed. RESULTS: MRI-defined gross total resection was associated with significantly longer LFFR and OS when compared with subtotal resection across most histomolecular subgroups. SG1-3 vs 4 distinguished differences in LFFR across several subgroups, but there were no consistent differences in outcomes when comparing degrees of dural treatment. Multivariable Cox including gene expression groups revealed that volumetric EOR (%) had a significantly higher AUC than SG (ΔAUC 0.07, P = .036) for 5-year OS; otherwise, there were no other differences between MRI-based or SG EOR paradigms for 5-year LFFR or OS. Additional significant differences for predicting 10-year LFFR all favored MRI-based EOR paradigms. CONCLUSION: Although SG and MRI-based EOR paradigms provide similar prognostic performance for predicting LFFR and OS in the era of molecular classification, MRI-based definitions may be preferred for future clinical trial inclusion criteria....

doi.org

We're finalizing the #BTM2026 scientific program and selecting the last short oral presentations. ⏳ Deadline extended: July 1 Join an exceptional international speaker line-up & help shape the discussion on brain tumors! 📍 Berlin | Oct 14–15, 2026 #NeuroOncology #BrainTumors

🏆 Congratulations to EANO member Gaetano Gargiulo on receiving a prestigious ERC Advanced Grant! As Group Leader of the Molecular Oncology Lab at @mdc-berlin.bsky.social and an #EANO Scientific Committee member, he has secured €2.5M for the MOIRA project on pediatric brain tumors. 👏

🌏🤝A proud moment for EANO at #ASNO2026! #EANO President Michael Platten & ASNO President Rakesh Jalali signed an MoU to strengthen global collaboration in #NeuroOncology. Proud to begin this new chapter with ASNO & SNO, advancing the field together.@neuroonc.bsky.social @michael-platten.bsky.social

🌏🤝 A proud moment for #EANO at #ASNO2026! EANO President Michael Platten and ASNO President Rakesh Jalali signed an MoU to strengthen global collaboration in #NeuroOncology. We look forward future joint initiatives together with ASNO and @neuroonc.bsky.social.

🧠 Join the next #EANOYoungsters Journal Club! 𝗢𝗽𝗲𝗻𝗶𝗻𝗴 𝗖𝗹𝗼𝘀𝗲𝗱 𝗗𝗼𝗼𝗿𝘀 "Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial" 📅 14 July 2026 🕓 16:30 CEST Register for free: zoom.us/webinar/regi...

🌍 Discover the latest in #NeuroOncology at #EANO2026 From clinical trial results to breakthrough innovations – explore advances in basic science, precision diagnostics, and novel treatment approaches. Join us in #Rome (IT), Sept 24–27, 2026 and register today! 👉 eano.eu/eano2026/reg...

Recently published in Neuro-Oncology: BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Association for Neuro-Oncology (EANO) consensus review on clinical management and future directions Read more: doi.org/10.1093/neuo... #EANOessentials

1/n Excited to share our new paper in Nature Cancer 🦀 Meet Hetairos (Greek- “companion”): an AI model that predicts >100 methylation-defined CNS tumour subtypes directly from a routine H&E slide 🧠 State of the art diagnostics- from the slide that’s already on every pathologists’ desk 🧵

🎗️ On #WorldBrainTumorDay 2026, "Advancing Brain Cancer Research" brought together the #NeuroOncology community, policymakers and patient advocates at the @europarl.europa.eu. #EANO representatives were proud to contribute to discussions on research and improving care for patients with #braintumors.

🧠 This #WorldBrainTumourDay, discover how EORTC’s Brain Tumour Group advances neuro-oncology through trials, research & collaboration. Learn more 👉 https://www.eortc.org/research_field/brain/

Each year on June 8th, #WorldBrainTumorDay is observed to raise awareness, educate people about brain tumors, and support those affected by it. #EANO is dedicated to foster advances in #NeuroOncology through innovative research, and concerted education & training. Together, we make a difference! 🎗️

👉 Insights into #radiotherapy – recently published in Radiotherapy and Oncology: Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS study Read more: lnkd.in/eZxX8cTi #EANOessentials #NeuroOncology #Glioma

👋 Students, Youngsters, Fellows, Postdocs, Nurses & AHP in #NeuroOncology! EANO invites you to register for the 21st Meeting of the European Association of Neuro-Oncology (#EANO2026) taking place from Sept 24-27, 2026 in Rome, IT. 👉 Register today! eano.eu/eano2026/reg... #btsm

‼️ Good news! Deadline for late-breaking abstract submission extended to June 09, 2026! Don't miss this opportunity to present your very latest reasearch breakthrough to the #NeuroOncology community at #EANO2026. Submit your abstract 👉 www.eano.eu/eano2025/abs... #btsm #braintumor

🙌 Updates in molecular diagnostics and glioma classification – recently published in Neuro-Oncology: cIMPACT-NOW update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas Open access: doi.org/10.1093/neuo... #EANOessentials #Astrocytoma #Oligodendroglioma #Glioma

cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas

Abstract. A working group of cIMPACT-NOW evaluated the literature on IDH-mutant gliomas for opportunities to improve pathology-based risk stratification an

doi.org

🚨 Tomorrow is the final day to submit your application for the #EANO2026Elections. If you have been thinking about taking on a role within #EANO, this is your last chance, applications close on 28 May 2026 at 23:59 (CEST). 👉 Apply via the EANO online application system on our website: www.eano.eu

📣 It’s today! Registration for #EANO2026 is now open. Join us in #Rome (IT), Sept 24–27, 2026, and connect with leading experts in #NeuroOncology. 🎟 Early Bird fees available until July 7, 2026. 👉 eano.eu/eano2026/reg... #Neurosurgery #Neuroradiology #Neurology #Oncology #PalliativeCare #Nursing

🙌 What a year for European Association of Neuro-Oncology abstract submissions! This year, we reached a record-breaking 1,166 submitted abstracts. We are truly inspired by the dedication of the #EANOcommunity and their commitment to advancing #NeuroOncology. Thank you! #EANO2026 #braintumor #btsm

Are you a nurse or allied health professional contributing to #NeuroOncology research? This award recognises exceptional contributions in the field. Nominations are still open: 📅 Apply by May 15 📩 Submit nomination to: awards@eano.eu 👉 Learn more: www.eano.eu/eanomeetings... #btsm #nurse

🚀 Take an active role in #EANO! Applications are now open for the 2026–2028 elections – from the Executive Board to multiple committees. Bring in your expertise, represent your field, and help drive #NeuroOncology forward across Europe. 🗓 Apply by May 28, 2026 📩 www.eano.eu #election #braintumor

🙌 Shine a light on outstanding contributions! #EANO2026 Awards & Scholarships are now open for nominations: ▫️ #Research ▫️ #YoungResearchers ▫️ #Nurses & #AHP ▫️ #Diversity & #Inclusion ▫️ #Leadership 🗓️ Deadline: May 15, 2026 👉 Submit nominations: awards@eano.eu More: www.eano.eu/eanomeetings...